2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Blood Loss, Surgical | D016063 | 6 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ruela AL et al. | Exploring the Phase Behavior of Monoolein/Oleic Acid/Water Systems for Enhanced Donezepil Administration for Alzheimer Disease Treatment. | 2016 | J Pharm Sci | pmid:26852841 |
| Gonçalves VSS et al. | Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs. | 2016 | Int J Pharm | pmid:27702697 |
| Shi C et al. | Exploring the effect of hydrophilic and hydrophobic structure of grafted polymeric micelles on drug loading. | 2016 | Int J Pharm | pmid:27576669 |
| Carneiro C et al. | Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis. | 2016 | Acta Biomater | pmid:27150234 |
| Freag MS et al. | Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies. | 2016 | Int J Nanomedicine | pmid:27703348 |
| Sato H et al. | Physicochemical stability study on cyclosporine A loaded dry-emulsion formulation with enhanced solubility. | 2015 | Chem. Pharm. Bull. | pmid:25743195 |
| Patil SS et al. | Liquid crystalline phase as a probe for crystal engineering of lactose: carrier for pulmonary drug delivery. | 2015 | Eur J Pharm Sci | pmid:25460546 |
| Rachmawati H et al. | Intraoral film containing insulin-phospholipid microemulsion: formulation and in vivo hypoglycemic activity study. | 2015 | AAPS PharmSciTech | pmid:25511810 |
| Barriga HM et al. | Temperature and pressure tuneable swollen bicontinuous cubic phases approaching nature's length scales. | 2015 | Soft Matter | pmid:25430049 |
| Salvati Manni L et al. | Phase behavior of a designed cyclopropyl analogue of monoolein: implications for low-temperature membrane protein crystallization. | 2015 | Angew. Chem. Int. Ed. Engl. | pmid:25418121 |